Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Asset Writedowns and Impairment (2017 - 2024)

Historic Asset Writedowns and Impairment for cbdMD (YCBD) over the last 8 years, with Q3 2024 value amounting to $921314.0.

  • cbdMD's Asset Writedowns and Impairment fell 9253.04% to $921314.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $921314.0, marking a year-over-year decrease of 9303.04%. This contributed to the annual value of $365979.0 for FY2025, which is 6027.64% down from last year.
  • cbdMD's Asset Writedowns and Impairment amounted to $921314.0 in Q3 2024, which was down 9253.04% from $12.3 million recorded in Q3 2023.
  • In the past 5 years, cbdMD's Asset Writedowns and Impairment ranged from a high of $30.8 million in Q2 2022 and a low of -$526628.0 during Q2 2020
  • Its 5-year average for Asset Writedowns and Impairment is $8.4 million, with a median of $921314.0 in 2024.
  • Per our database at Business Quant, cbdMD's Asset Writedowns and Impairment tumbled by 15808.07% in 2020 and then surged by 168893.63% in 2022.
  • cbdMD's Asset Writedowns and Impairment (Quarter) stood at -$526628.0 in 2020, then surged by 3552.78% to $18.2 million in 2021, then plummeted by 95.13% to $884892.0 in 2022, then skyrocketed by 1293.85% to $12.3 million in 2023, then plummeted by 92.53% to $921314.0 in 2024.
  • Its Asset Writedowns and Impairment stands at $921314.0 for Q3 2024, versus $12.3 million for Q3 2023 and $884892.0 for Q4 2022.